5,156
Participants
Start Date
May 6, 2002
Primary Completion Date
March 31, 2017
Study Completion Date
September 30, 2017
Hydrolysed infant formula
Participants in the Hydrolysed infant formula -group received the test formula, casein hydrolysate (Nutramigen™, Mead Johnson Nutritionals), not containing antigenic CM protein, whenever breast milk is not available.
Nonhydrolysed infant formula
Participants in the Nonydrolysed infant formula -group received the CM protein containing control formula which has an addition (20 %) of Nutramigen, whenever breast milk is not available.
3rd Faculty of Medicine, Charles University, University Hospital Vinohrady, Prague
Semmelweis Medical University, Budapest
Centre Hospitalier de Luxembourg, Luxembourg
Children's Hospital at Westmead, Westmead
Hospital Clinico San Carlos, Madrid
Kinderkrankenhaus auf der Bult, Hanover
The University of South Florida, Tampa
Hospital de Cruces, Barakaldo
Tartu University Children's Hospital, Tartu
University of Pittsburgh, Pittsburgh
Robarts Research Institute, London
University of Helsinki, Helsinki
St. Michele Hospital, Cagliari
University Campus Bio-Medico of Rome, Rome
Sophia Children's Hospital, Rotterdam
Medical University of Wroclaw, Wroclaw
University of Linkoping, Linköping
University Children's Hospital, Zurich
United States Congress
FED
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
Juvenile Diabetes Research Foundation
OTHER
European Community (EC)
OTHER_GOV
European Foundation for the Study of Diabetes
OTHER
Mead Johnson Nutrition
INDUSTRY
Academy of Finland
OTHER
Diabetes Research Foundation, Finland
OTHER
Dutch Diabetes Research Foundation
OTHER
University of Helsinki
OTHER